CMMB - CIK 0001534248
Chemomab Therapeutics Ltd. has filed 347 documents with the SEC between 2011 and 2026. The most frequent type is 6-k (60 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2021-03-12 | 2020-04-23 |
| New insider ownership | 3 | 2021-03-12 | 2020-04-23 |
| New insider ownership | 3 | 2021-03-11 | 2020-10-20 |
| Insider trade | 4 | 2021-03-11 | 2020-04-23 |
| New insider ownership | 3 | 2021-03-11 | 2020-04-23 |
| 425 | - | 2021-03-10 | - |
| Major company event | 8-K | 2021-03-10 | 2021-03-09 |
| Annual report | 10-K | 2021-03-09 | 2020-12-31 |
| 425 | - | 2021-03-09 | - |
| 424B3 | - | 2021-02-12 | - |
| EFFECT | - | 2021-02-10 | - |
| Company correspondence | CORRESP | 2021-02-10 | - |
| Company correspondence | CORRESP | 2021-02-10 | - |
| S-4/A | - | 2021-02-10 | - |
| 425 | - | 2021-02-08 | - |
| Major company event | 8-K | 2021-02-08 | 2021-02-08 |
| 425 | - | 2021-02-02 | - |
| SEC correspondence | UPLOAD | 2021-01-15 | - |
| S-4 | - | 2021-01-13 | - |
| 425 | - | 2021-01-11 | - |
| 425 | - | 2021-01-05 | - |
| Activist ownership stake (update) | SC 13D/A | 2020-12-21 | - |
| Activist ownership stake (update) | SC 13D/A | 2020-12-18 | - |
| Proxy materials | DEFA14A | 2020-12-15 | - |
| Major company event | 8-K | 2020-12-15 | 2020-12-14 |
| Quarterly report | 10-Q | 2020-11-16 | 2020-09-30 |
| Major company event | 8-K | 2020-10-20 | 2020-10-20 |
| Quarterly report | 10-Q | 2020-08-14 | 2020-06-30 |
| Major company event | 8-K | 2020-07-15 | 2020-07-15 |
| Major company event | 8-K | 2020-07-09 | 2020-07-09 |
| Activist ownership stake (update) | SC 13D/A | 2020-05-22 | - |
| Major company event | 8-K | 2020-05-21 | 2020-05-21 |
| Quarterly report | 10-Q | 2020-05-07 | 2020-03-31 |
| New insider ownership | 3 | 2020-05-07 | 2020-05-01 |
| Major company event | 8-K | 2020-05-06 | 2020-05-05 |
| Major company event | 8-K | 2020-04-24 | 2020-04-24 |
| Proxy materials | DEFA14A | 2020-04-17 | - |
| Major company event | 8-K | 2020-04-15 | 2020-04-15 |
| SEC correspondence | UPLOAD | 2020-04-07 | - |
| Proxy statement | DEF 14A | 2020-04-06 | 2020-04-23 |
| Company correspondence | CORRESP | 2020-04-06 | - |
| SEC correspondence | UPLOAD | 2020-04-06 | - |
| Activist ownership stake (update) | SC 13D/A | 2020-03-31 | - |
| PRE 14A | - | 2020-03-30 | 2020-04-23 |
| Employee stock plan | S-8 | 2020-03-17 | - |
| Annual report | 10-K | 2020-03-17 | 2019-12-31 |
| Major company event | 8-K | 2020-03-16 | 2020-03-16 |
| Major company event | 8-K | 2020-02-10 | 2020-02-10 |
| Major company event | 8-K | 2020-02-04 | 2020-02-03 |
| Major company event | 8-K | 2020-01-31 | 2020-01-31 |